Mode
Text Size
Log in / Sign up
N/A N=101

Angiographic Comparison in an Observational Study of CADence (The AMBIENCE Study)

Coronary Artery Disease

Enrolled (actual)
101
Serious AEs
0.0%
Results posted
Mar 2021
Primary outcome: Primary: Percent of Participants With Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as Accurate and Appropriate — 101; 31 Participants

Study Design & Population

Study type
Observational
Phase
N/A
Interventions
CADence (Device)
Age
Adult, Older Adult · 41+ yrs
Sex
All
Sponsor
AUM Cardiovascular, Inc.
Primary completion
Jun 2016

Outcome Measures

OutcomeResultp-value
PRIMARY
Percent of Participants With Positive Agreement of CADence Device Under Normal Use Conditions as Compared to Coronary Angiograms as Accurate and Appropriate
101; 31
SECONDARY
Number of Participants With CADence-related Adverse Events
0; 101

Summary

This is a prospective, multi-center study to capture information on sensitivity and specificity of CADence using coronary angiogram as the gold standard, on subjects who are already scheduled for coronary angiography.

Eligibility Criteria

Inclusion Criteria

  • Age >40 years
  • Clinical indication for coronary angiogram
  • Willing and able to give informed consent

Exclusion Criteria

  • Body Mass Index (BMI) 40
  • Prior bypass surgery or coronary stenting
  • Presence of pacemaker/defibrillator
  • Presence of artificial valve
  • Presence of obvious cyanotic or pre-diagnosed congenital heart defect and coarctation of the aorta
  • Presence of murmurs, including valve lesions, ventricular septal defects and arteriovenous fistulae
  • Presence of moderate-severe valve disease
  • Left Ventricular Assist Device (LVAD)
  • Presence of scars on the site thorax areas
  • Participation in trial within 30 days prior to collecting CADence data except participation in registry studies.
  • Asthma or chronic obstructive pulmonary disease (COPD) with active wheezing
  • Inability to lie in supine position
  • Heart Transplant
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT02515825). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search